Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 791

    1.

    Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).

    López-Bermejo A, Khosravi J, Fernández-Real JM, Hwa V, Pratt KL, Casamitjana R, Garcia-Gil MM, Rosenfeld RG, Ricart W.

    Diabetes. 2006 Aug;55(8):2333-9.PMID: 16873698 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.

    Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H.

    Diabetes Metab Res Rev. 1999 Sep-Oct;15(5):314-22.PMID: 10585616 [PubMed - indexed for MEDLINE]Related articles

    4.

    Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.

    Jehle PM, Jehle DR, Mohan S, Böhm BO.

    J Endocrinol. 1998 Nov;159(2):297-306.PMID: 9795371 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups.

    Heald AH, Anderson SG, Ivison F, Laing I, Gibson JM, Cruickshank K.

    Atherosclerosis. 2003 Sep;170(1):79-86.PMID: 12957685 [PubMed - indexed for MEDLINE]Related articles

    7.

    Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women.

    Söderberg S, Ahrén B, Eliasson M, Dinesen B, Brismar K, Olsson T.

    Eur J Endocrinol. 2001 Mar;144(3):283-90.PMID: 11248749 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes.

    Heald AH, Siddals KW, Fraser W, Taylor W, Kaushal K, Morris J, Young RJ, White A, Gibson JM.

    Diabetes. 2002 Aug;51(8):2629-36.PMID: 12145180 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth.

    Kajantie E, Fall CH, Seppälä M, Koistinen R, Dunkel L, Ylihärsilä H, Osmond C, Andersson S, Barker DJ, Forsén T, Holt RI, Phillips DI, Eriksson J.

    J Clin Endocrinol Metab. 2003 Mar;88(3):1059-65.PMID: 12629086 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome.

    Mohamed-Ali V, Pinkney JH, Panahloo A, Cwyfan-Hughes S, Holly JM, Yudkin JS.

    Clin Endocrinol (Oxf). 1999 Feb;50(2):221-8.PMID: 10396366 [PubMed - indexed for MEDLINE]Related articles

    12.

    High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.

    Amin S, Riggs BL, Melton LJ 3rd, Achenbach SJ, Atkinson EJ, Khosla S.

    J Bone Miner Res. 2007 Jun;22(6):799-807.PMID: 17352648 [PubMed - indexed for MEDLINE]Related articles

    13.

    Relationship between serum leptin and the insulin-like growth factor-I system in humans.

    Grégoire Nyomba BL, Johnson M, Berard L, Murphy LJ.

    Metabolism. 1999 Jul;48(7):840-4.PMID: 10421222 [PubMed - indexed for MEDLINE]Related articles

    14.

    Plasma adiponectin concentration and tumor necrosis factor-alpha system activity in lean non-diabetic offspring of type 2 diabetic subjects.

    Kowalska I, Straczkowski M, Nikołajuk A, Krukowska A, Kinalska I, Górska M.

    Eur J Endocrinol. 2006 Feb;154(2):319-24.PMID: 16452547 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Changes in insulin-like growth factor (IGF)-binding proteins after IGF-I injections in noninsulin-dependent diabetics.

    Young SC, Clemmons DR.

    J Clin Endocrinol Metab. 1994 Mar;78(3):609-14.PMID: 7510305 [PubMed - indexed for MEDLINE]Related articles

    16.

    Associations of adiposity from childhood into adulthood with insulin resistance and the insulin-like growth factor system: 65-year follow-up of the Boyd Orr Cohort.

    Martin RM, Holly JM, Davey Smith G, Gunnell D.

    J Clin Endocrinol Metab. 2006 Sep;91(9):3287-95. Epub 2006 Jun 20.PMID: 16787980 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Relationship between non-enzymatic glycosylation and changes in serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in patients with type 2 diabetes mellitus.

    Cortizo AM, Lee PD, Cédola NV, Jasper H, Gagliardino JJ.

    Acta Diabetol. 1998 Jul;35(2):85-90.PMID: 9747960 [PubMed - indexed for MEDLINE]Related articles

    18.

    Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?

    Axelsson J, Qureshi AR, Divino-Filho JC, Bárány P, Heimbürger O, Lindholm B, Stenvinkel P.

    Eur J Clin Nutr. 2006 Jun;60(6):718-26. Epub 2006 Jan 4.PMID: 16391585 [PubMed - indexed for MEDLINE]Related articles

    19.

    The relationship between the circulating IGF system and the presence of retinopathy in Type 1 diabetic patients.

    Frystyk J, Bek T, Flyvbjerg A, Skjaerbaek C, Ørskov H.

    Diabet Med. 2003 Apr;20(4):269-76.PMID: 12675639 [PubMed - indexed for MEDLINE]Related articles

    20.

    Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden.

    Clauson PG, Brismar K, Hall K, Linnarsson R, Grill V.

    Scand J Clin Lab Invest. 1998 Jul;58(4):353-60.PMID: 9741824 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data